Recombinant human serum albumin (OsrHSA) has emerged as a significant innovation in the sector of biopharmaceuticals, featuring promising advancements across numerous clinical and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA offers a safer, far more reputable alternate for therapeut